A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT

NCT00727597 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus Infections

Interventions

DRUG: Efavirenz 600mg
DRUG: Boosted Lexiva

Sponsor

Georgetown University

Collaborators

[object Object]